HISTORY: Formation Ranbaxy was started by Ranbir Singh and Gurbax Singh in 1937 as a distributor for a Japanese company Shionogi. The name Ranbaxy is a combination of the names of its first owners Ranbir and Gurbax. Bhai Mohan Singh bought the company in 1952 from his cousins Ranbir and Gurbax. After Bhai Mohan Singh’s son Parvinder Singh joined the company in 1967‚ the company saw an increase in scale. His sons Malvinder Mohan Singh and Shivinder Mohan Singh sold the company to the Japanese company
Premium Ranbaxy Laboratories Generic drug
evaluate all possibilities that come with an IJV‚ it could lead to potential losses. Eli Lilly Ranbaxy is an example of a joint venture that was pursued with the right strategy‚ which was a result due to a changing US pharmaceutical market and a rapidly expanding India market. The two companies in this IJV were both significant players within their home countries‚ Eli Lilly and Company in the US and Ranbaxy Laboratories Limited from India. When the possibility of establishing a joint venture was approached
Premium Joint venture Generic drug Ranbaxy Laboratories
A Project report on Financial Analysis of Ranbaxy Laboratories Limited Index S. No. Content Page No. 1 Executive Summary of ‘Ranbaxy Laboratories Limited’ 3 2 Capital Expenditure at Ranbaxy 7 3 Account Balances for properties‚ plant and equipment 8 4 Capital Structure at Ranbaxy 9 5 Beta measure of the company 11 6 Weighted Average cost of capital 13 7 Debt-Equity ratio 14 8 Du Pont Analysis 15 9 Comments
Premium Financial ratios Inventory Generic drug
ELI LILLY IN INDIA RETHINKING THE JOINT VENTURE Kishore – 01 STRATEGY Abhay Abhishek Kunal – 05 Anil Kumar Jadli – 11 J.Harish – 25 Khushal Malik – 28 Sharad Singh – 49 PHARMACEUTICAL INDUSTRY – Global Trend • • • • Mainly concentrated in the United States‚ Europe‚ and Japan Developing a drug from discovery to launch took 10 to 12 years. Cost of development of drug is between $500-$800 million. Drugs were strictly controlled by government agencies: o Food and Drug Administration (FDA) – USA‚
Premium Generic drug Pharmaceutical industry Ranbaxy Laboratories
appropriate because of the internal or external factors‚ strategic repositioning should be launched to change the identity of the brands and products to the target markets is essential to maintain business health. According to the article provided‚ “Evaluating…Repositioning Strategies‚ Marcel & Peter”‚ repositioning can be classified as 3 main types: namely‚ Zero‚ Gradual and Radical. 2.1 Zero repositioning Zero repositioning represents a company remain unchanged when there is changing retailing
Premium Marketing Change Brand management
(8NBNG169) A Thesis on “TO STUDY PROMOTIONAL STRATEGY ADOPTED BY RANBAXY LABORATORIES LTD RELATED TO RANITIDINE-150mg (Antiulcerant) IN NAGPUR CITY” INTRODUCTION OBJECTIVES:- To study the overview of Indian Pharmaceutical Market. To study the culture of Ranbaxy Lab. To find out the promotional strategies used by Ranbaxy with respect to ‘Histac’ tab. To find out various promotional strategies used by Ranbaxy to acquire market share in Nagpur city. To study the competitors of
Premium Generic drug Pharmaceutical industry Gastroesophageal reflux disease
Brand Repositioning and Types of Brand Repositioning Brand Repositioning is changing the positioning of a brand. A particular positioning statement may not work with a brand. For instance‚ Dettol toilet soap was positioned as a beauty soap initially. This was not in line with its core values. Dettol‚ the parent brand (anti-septic liquid) was known for its ability to heal cuts and gashes. The extension’s ’beauty’ positioning was not in tune with the parent’s “germ-kill” positioning. The soap
Premium Brand Brand management Target market
Dinesh G. Mhatre EMB III‚ Roll No. 6 Topic: Repositioning of brand Cadbury Objective: • • • • • To review the brand repositioning strategies of different sub-brands of Cadbury in India. To analyze the brand repositioning strategies of Titan watches. To study consumer awareness and perception about the brand repositioning strategies of Cadbury. To understand the ability of Cadbury to motivate consumers to buy their products Desire of Cadbury to expand their target market from kids to younger
Premium Chocolate
Ranbaxy – Daiichi Sankyo Deal Akash Bangani Dipika Bhura Gaurav Khetan Neetu Rathod 12065 12077 12082 12118 Agenda • • • • • • • • • • Industry Overview Companies’ Profiles Snapshot of the deal Financing the deal Benefits to Daiichi Benefits to Ranbaxy Synergies Post Acquisition challenges Recent Developments Conclusion Indian Pharmaceutical Industry • Present size of $14 billion. • Ranks 4th in world in terms of production and 13th in terms of consumption. • Highly fragmented. 325 large
Premium Generic drug Pharmaceutical industry 3rd millennium
{draw:frame} University of Derby/Buxton Hospitality Management MA Hotel Renovation A Tool For Repositioning In the Hotel Industry Submission Date: 7th May 2009 Business Analysis and Decision Making Student: Nana Yaa Addo Module Leader: Norman Dindsdale Introduction The hospitality industry has grown phenomenally since 2001 and has been driven by both leisure and business demand (kloppers 2005). The needs of the consumer have now become dynamic rather than static. Consumers
Premium Net present value Hotel Investment